Novavax, Inc. (NVAX)
USD 6.17
(-1.12%)
USD 6.17
(-1.12%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -566.51 Million USD | 35.63% |
| 2022 | -644.73 Million USD | 61.77% |
| 2021 | -1.68 Billion USD | -304.73% |
| 2020 | -416.71 Million USD | -245.59% |
| 2019 | -120.58 Million USD | 30.67% |
| 2018 | -173.91 Million USD | -1.29% |
| 2017 | -171.71 Million USD | 36.19% |
| 2016 | -269.11 Million USD | -71.15% |
| 2015 | -157.23 Million USD | -87.88% |
| 2014 | -83.69 Million USD | -59.61% |
| 2013 | -52.43 Million USD | -76.75% |
| 2012 | -29.66 Million USD | -37.47% |
| 2011 | -21.57 Million USD | 43.94% |
| 2010 | -38.49 Million USD | -2.97% |
| 2009 | -37.38 Million USD | -8.8% |
| 2008 | -34.36 Million USD | -13.51% |
| 2007 | -30.27 Million USD | -23.02% |
| 2006 | -24.6 Million USD | -168.31% |
| 2005 | -9.17 Million USD | 62.51% |
| 2004 | -24.46 Million USD | -52.39% |
| 2003 | -16.05 Million USD | 25.53% |
| 2002 | -21.55 Million USD | -132.93% |
| 2001 | -9.25 Million USD | 27.37% |
| 2000 | -12.74 Million USD | -177.0% |
| 1999 | -4.6 Million USD | 11.54% |
| 1998 | -5.2 Million USD | -8.33% |
| 1997 | -4.8 Million USD | 12.73% |
| 1996 | -5.5 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 162.11 Million USD | 216.05% |
| 2024 Q1 | -138.73 Million USD | 24.43% |
| 2023 FY | -415.02 Million USD | 35.63% |
| 2023 Q3 | -125.63 Million USD | -326.54% |
| 2023 Q2 | 55.45 Million USD | 117.73% |
| 2023 Q1 | -312.76 Million USD | -28.25% |
| 2023 Q4 | -183.56 Million USD | -46.12% |
| 2022 Q3 | -127.18 Million USD | 73.66% |
| 2022 Q4 | -243.87 Million USD | -91.75% |
| 2022 Q1 | 209.29 Million USD | 125.37% |
| 2022 FY | -644.73 Million USD | 61.77% |
| 2022 Q2 | -482.96 Million USD | -330.76% |
| 2021 FY | -1.68 Billion USD | -304.73% |
| 2021 Q2 | -345.82 Million USD | -65.76% |
| 2021 Q1 | -208.63 Million USD | -14.1% |
| 2021 Q3 | -307.14 Million USD | 11.19% |
| 2021 Q4 | -824.97 Million USD | -168.59% |
| 2020 Q3 | -193.94 Million USD | -1039.03% |
| 2020 Q2 | -17.02 Million USD | 25.64% |
| 2020 FY | -416.71 Million USD | -245.59% |
| 2020 Q1 | -22.89 Million USD | 20.23% |
| 2020 Q4 | -182.85 Million USD | 5.72% |
| 2019 Q4 | -28.7 Million USD | -91.53% |
| 2019 FY | -120.58 Million USD | 30.67% |
| 2019 Q3 | -14.98 Million USD | 59.13% |
| 2019 Q1 | -40.22 Million USD | 13.52% |
| 2019 Q2 | -36.66 Million USD | 8.84% |
| 2018 Q1 | -43.51 Million USD | 8.94% |
| 2018 FY | -173.91 Million USD | -1.29% |
| 2018 Q3 | -41.9 Million USD | 0.22% |
| 2018 Q2 | -41.99 Million USD | 3.49% |
| 2018 Q4 | -46.51 Million USD | -11.01% |
| 2017 FY | -171.71 Million USD | 36.19% |
| 2017 Q2 | -41.47 Million USD | -1.58% |
| 2017 Q3 | -41.62 Million USD | -0.38% |
| 2017 Q4 | -47.78 Million USD | -14.79% |
| 2017 Q1 | -40.82 Million USD | 24.46% |
| 2016 Q3 | -63.3 Million USD | 17.24% |
| 2016 FY | -269.11 Million USD | -71.15% |
| 2016 Q2 | -76.49 Million USD | -1.64% |
| 2016 Q4 | -54.04 Million USD | 14.63% |
| 2016 Q1 | -75.26 Million USD | 4.61% |
| 2015 Q3 | -33.19 Million USD | -59.45% |
| 2015 Q4 | -78.9 Million USD | -137.66% |
| 2015 Q2 | -20.82 Million USD | 14.36% |
| 2015 Q1 | -24.31 Million USD | 23.22% |
| 2015 FY | -157.23 Million USD | -87.88% |
| 2014 Q3 | -19.78 Million USD | -10.86% |
| 2014 FY | -83.69 Million USD | -59.61% |
| 2014 Q2 | -17.85 Million USD | -24.09% |
| 2014 Q1 | -14.38 Million USD | -0.93% |
| 2014 Q4 | -31.66 Million USD | -60.01% |
| 2013 Q2 | -12.89 Million USD | -28.92% |
| 2013 Q1 | -10 Million USD | -5.37% |
| 2013 FY | -52.43 Million USD | -76.75% |
| 2013 Q4 | -14.25 Million USD | 6.72% |
| 2013 Q3 | -15.27 Million USD | -18.46% |
| 2012 FY | -29.66 Million USD | -37.47% |
| 2012 Q2 | -5.85 Million USD | 21.59% |
| 2012 Q3 | -6.84 Million USD | -16.98% |
| 2012 Q4 | -9.49 Million USD | -38.63% |
| 2012 Q1 | -7.46 Million USD | -75.32% |
| 2011 Q4 | -4.25 Million USD | -7.33% |
| 2011 FY | -21.57 Million USD | 43.94% |
| 2011 Q1 | -7.43 Million USD | -5.66% |
| 2011 Q2 | -5.92 Million USD | 20.31% |
| 2011 Q3 | -3.96 Million USD | 32.98% |
| 2010 FY | -38.49 Million USD | -2.97% |
| 2010 Q2 | -9.46 Million USD | 17.34% |
| 2010 Q1 | -11.45 Million USD | 19.08% |
| 2010 Q4 | -7.03 Million USD | 33.28% |
| 2010 Q3 | -10.53 Million USD | -11.31% |
| 2009 Q3 | -8.26 Million USD | -5.52% |
| 2009 FY | -37.38 Million USD | -8.8% |
| 2009 Q2 | -7.83 Million USD | -9.71% |
| 2009 Q4 | -14.15 Million USD | -71.31% |
| 2009 Q1 | -7.13 Million USD | 22.51% |
| 2008 Q1 | -7.22 Million USD | -119.05% |
| 2008 FY | -34.36 Million USD | -13.51% |
| 2008 Q4 | -9.21 Million USD | 5.31% |
| 2008 Q3 | -9.72 Million USD | -18.55% |
| 2008 Q2 | -8.2 Million USD | -13.63% |
| 2007 Q1 | -8.99 Million USD | -31.46% |
| 2007 Q4 | -3.29 Million USD | 64.39% |
| 2007 FY | -30.27 Million USD | -23.02% |
| 2007 Q3 | -9.25 Million USD | -6.1% |
| 2007 Q2 | -8.72 Million USD | 2.97% |
| 2006 Q1 | -5.03 Million USD | -175.06% |
| 2006 Q3 | -5.69 Million USD | 19.1% |
| 2006 Q2 | -7.03 Million USD | -39.78% |
| 2006 FY | -24.6 Million USD | -168.31% |
| 2006 Q4 | -6.84 Million USD | -20.13% |
| 2005 Q4 | 6.7 Million USD | 399.87% |
| 2005 Q1 | -8.41 Million USD | 15.05% |
| 2005 Q2 | -5.22 Million USD | 37.92% |
| 2005 Q3 | -2.23 Million USD | 57.19% |
| 2005 FY | -9.17 Million USD | 62.51% |
| 2004 FY | -24.46 Million USD | -52.39% |
| 2004 Q1 | -4.89 Million USD | -60.0% |
| 2004 Q2 | -7.34 Million USD | -49.92% |
| 2004 Q3 | -2.32 Million USD | 68.39% |
| 2004 Q4 | -9.9 Million USD | -327.07% |
| 2003 Q4 | -3.06 Million USD | -3.38% |
| 2003 Q3 | -2.96 Million USD | 36.1% |
| 2003 Q1 | -5.4 Million USD | -10.4% |
| 2003 Q2 | -4.63 Million USD | 14.24% |
| 2003 FY | -16.05 Million USD | 25.53% |
| 2002 FY | -21.55 Million USD | -132.93% |
| 2002 Q4 | -4.89 Million USD | 22.83% |
| 2002 Q3 | -6.33 Million USD | -21.11% |
| 2002 Q2 | -5.23 Million USD | -2.75% |
| 2002 Q1 | -5.09 Million USD | -67.13% |
| 2001 Q2 | -1.68 Million USD | 21.88% |
| 2001 Q3 | -2.37 Million USD | -41.02% |
| 2001 Q4 | -3.04 Million USD | -28.5% |
| 2001 FY | -9.25 Million USD | 27.37% |
| 2001 Q1 | -2.15 Million USD | 57.65% |
| 2000 Q3 | -3.37 Million USD | -19.42% |
| 2000 Q2 | -2.82 Million USD | -94.3% |
| 2000 Q1 | -1.45 Million USD | -32.27% |
| 2000 FY | -12.74 Million USD | -177.0% |
| 2000 Q4 | -5.08 Million USD | -50.59% |
| 1999 Q3 | -1.8 Million USD | -125.0% |
| 1999 Q2 | -800 Thousand USD | 11.11% |
| 1999 FY | -4.6 Million USD | 11.54% |
| 1999 Q1 | -900 Thousand USD | 47.06% |
| 1999 Q4 | -1.1 Million USD | 38.89% |
| 1998 Q2 | -1.3 Million USD | -44.44% |
| 1998 Q1 | -900 Thousand USD | 18.18% |
| 1998 FY | -5.2 Million USD | -8.33% |
| 1998 Q3 | -1.3 Million USD | 0.0% |
| 1998 Q4 | -1.7 Million USD | -30.77% |
| 1997 Q4 | -1.1 Million USD | 8.33% |
| 1997 Q3 | -1.2 Million USD | 7.69% |
| 1997 Q1 | -1.1 Million USD | 38.89% |
| 1997 Q2 | -1.3 Million USD | -18.18% |
| 1997 FY | -4.8 Million USD | 12.73% |
| 1996 Q2 | -1.3 Million USD | -18.18% |
| 1996 FY | -5.5 Million USD | 0.0% |
| 1996 Q3 | -1 Million USD | 23.08% |
| 1996 Q1 | -1.1 Million USD | 0.0% |
| 1996 Q4 | -1.8 Million USD | -80.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | -138.826% |
| Alkermes plc | 414.12 Million USD | 236.798% |
| Agenus Inc. | -159.54 Million USD | -255.07% |
| Aptorum Group Limited | -10.52 Million USD | -5283.381% |
| Ardelyx, Inc. | -63.27 Million USD | -795.302% |
| Dyadic International, Inc. | -8.22 Million USD | -6783.706% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -47426.091% |
| Lantern Pharma Inc. | -17.87 Million USD | -3068.837% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -2719.895% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -676.266% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -589.22% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -2817.375% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -5263.164% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -966.346% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -48.888% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -2230.687% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -1395.976% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -339.197% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -575.109% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -3130.007% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -1187.232% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -2180.273% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -307.471% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -100.766% |
| AlloVir, Inc. | -181.33 Million USD | -212.418% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -176.344% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1836.26% |
| Bicycle Therapeutics plc | -189.94 Million USD | -198.248% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -229.785% |
| ChromaDex Corporation | -5.59 Million USD | -10018.075% |
| Chimerix, Inc. | -93.06 Million USD | -508.726% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -1156.754% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -388.123% |
| CRISPR Therapeutics AG | -222.53 Million USD | -154.568% |
| Precision BioSciences, Inc. | -43.73 Million USD | -1195.297% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -197.364% |
| Fortress Biotech, Inc. | -142.34 Million USD | -297.993% |
| Fortress Biotech, Inc. | -142.34 Million USD | -297.993% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -479.883% |
| ImmuCell Corporation | -5.74 Million USD | -9755.66% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -321.42% |
| Immix Biopharma, Inc. | -16.14 Million USD | -3409.739% |
| Incyte Corporation | 620.52 Million USD | 191.295% |
| Innoviva, Inc. | 176.7 Million USD | 420.59% |
| IO Biotech, Inc. | -91.44 Million USD | -519.524% |
| Jaguar Health, Inc. | -34.29 Million USD | -1552.069% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -233.357% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 4843.854% |
| ContextLogic Inc. | -328 Million USD | -72.717% |
| MiMedx Group, Inc. | 37.11 Million USD | 1626.326% |
| MEI Pharma, Inc. | 14.54 Million USD | 3995.688% |
| NextCure, Inc. | -67.63 Million USD | -737.576% |
| Onconetix, Inc. | -36.03 Million USD | -1472.131% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -1258.084% |
| Opthea Limited | -191.84 Million USD | -195.3% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -20486.738% |
| Vaxcyte, Inc. | -468.04 Million USD | -21.039% |
| PDS Biotechnology Corporation | -43.04 Million USD | -1216.083% |
| Precigen, Inc. | -88.92 Million USD | -537.08% |
| Pharming Group N.V. | -4.87 Million USD | -11509.917% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -238.596% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1803.855% |
| PureTech Health plc | -146.19 Million USD | -287.493% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -2664.682% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -140.457% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -2230.687% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -106.752% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1833.155% |
| Acelyrin, Inc. | -422.06 Million USD | -34.224% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -4393181.396% |
| Summit Therapeutics Inc. | -89.73 Million USD | -531.309% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -1428.467% |
| Senti Biosciences, Inc. | -92.72 Million USD | -510.945% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -393.593% |
| Elevation Oncology, Inc. | -45.44 Million USD | -1146.586% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -1553.226% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -14270.982% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -17816.224% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1615.608% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -6564.051% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -733.153% |
| Seer, Inc. | -103.46 Million USD | -447.549% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -761.496% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -687.554% |
| ESSA Pharma Inc. | -32.13 Million USD | -1662.959% |
| GlycoMimetics, Inc. | -39.27 Million USD | -1342.411% |
| GT Biopharma, Inc. | -13.57 Million USD | -4072.886% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -158.42% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -1124.73% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 752.572% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -898.099% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -999.893% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -5600.656% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | -12.333% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -8112.685% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -1017.533% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -118.175% |
| Aptose Biosciences Inc. | -52.35 Million USD | -982.036% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -3828.437% |
| Soligenix, Inc. | -7.69 Million USD | -7259.255% |
| Century Therapeutics, Inc. | -146.54 Million USD | -286.576% |
| Kura Oncology, Inc. | -165.8 Million USD | -241.675% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -506.166% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -6709.845% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -22728.099% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -8637.06% |
| Autolus Therapeutics plc | -195.02 Million USD | -190.477% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -569.184% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -669.068% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -2580.44% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -149.526% |
| GRI Bio, Inc. | -11.38 Million USD | -4875.068% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -12445.322% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -331.815% |
| IGM Biosciences, Inc. | -263.46 Million USD | -115.027% |
| INmune Bio, Inc. | -29.74 Million USD | -1804.815% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -412.147% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1387.869% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -3445.267% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -3492.145% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -827.217% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -426.879% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -105.253% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -178.796% |
| Verastem, Inc. | -92.08 Million USD | -515.211% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -1101.89% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -207.644% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -378.553% |
| Histogen Inc. | -10.64 Million USD | -5222.851% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -3561.534% |
| Surrozen, Inc. | -45.78 Million USD | -1137.464% |
| Organovo Holdings, Inc. | -15.08 Million USD | -3655.21% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -11029.366% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -855.629% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -1004.439% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -2140.945% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -7322.018% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -230.746% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -1069.319% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -624.392% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -3621.959% |
| Apollomics, Inc. | -54.83 Million USD | -933.138% |
| Amarin Corporation plc | -67.58 Million USD | -738.183% |
| Mesoblast Limited | -58.79 Million USD | -863.552% |
| Turnstone Biologics Corp. | -59.03 Million USD | -859.668% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -242.241% |
| Synaptogenix, Inc. | -8.31 Million USD | -6714.06% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -3783.937% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -517.848% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -11723.333% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -6314.856% |
| Exelixis, Inc. | 170.88 Million USD | 431.516% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1380.61% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -265.342% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | -9.551% |
| NLS Pharmaceutics AG | -11.8 Million USD | -4698.069% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -6944.487% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -1788.811% |
| Gritstone bio, Inc. | -154.63 Million USD | -266.356% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -722.688% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -3208.47% |
| Avid Bioservices, Inc. | -18.67 Million USD | -2933.039% |
| Insmed Incorporated | -709.62 Million USD | 20.168% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -3510.699% |
| MediWound Ltd. | -15.29 Million USD | -3605.108% |
| OmniAb, Inc. | -69.41 Million USD | -716.075% |
| Alector, Inc. | -151.74 Million USD | -273.343% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -424.63% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -986.352% |
| Zai Lab Limited | -366.57 Million USD | -54.542% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -78.836% |
| Aura Biosciences, Inc. | -84.99 Million USD | -566.554% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -130.759% |
| Immunic, Inc. | -99.22 Million USD | -470.947% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -295.724% |
| Veracyte, Inc. | -85.79 Million USD | -560.308% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -101.022% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3886.707% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -8124.671% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -2914.54% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 197.914% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -2125.714% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1560.005% |
| TG Therapeutics, Inc. | 20.63 Million USD | 2845.655% |
| Galecto, Inc. | -39.9 Million USD | -1319.649% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -1246.463% |
| Fortrea Holdings Inc. | 63.1 Million USD | 997.799% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -303.369% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1861.739% |
| XBiotech Inc. | -37.51 Million USD | -1410.293% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -722.688% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -744.027% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -425.004% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -2106.727% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -963.032% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 0.474% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -621.744% |
| Vaxxinity, Inc. | -58.28 Million USD | -871.967% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -446.251% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -2445.758% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -555.563% |
| NexImmune, Inc. | -29.19 Million USD | -1840.606% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -9980.03% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -3785.168% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 113.998% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -2125.19% |
| Scopus BioPharma Inc. | -11.71 Million USD | -4735.825% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -345.854% |
| Ainos, Inc. | -13.2 Million USD | -4189.671% |
| Pluri Inc. | -22.15 Million USD | -2456.688% |
| Prothena Corporation plc | -191.03 Million USD | -196.547% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -310.402% |
| Celularity Inc. | -192.28 Million USD | -194.617% |
| Rallybio Corporation | -78.93 Million USD | -617.72% |
| Cue Biopharma, Inc. | -52.14 Million USD | -986.331% |
| MeiraGTx Holdings plc | -137.06 Million USD | -313.328% |
| Omeros Corporation | -164.53 Million USD | -244.321% |
| Humacyte, Inc. | -100.04 Million USD | -466.245% |
| Immunocore Holdings plc | -59.64 Million USD | -849.741% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -2952.487% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -2213.895% |
| Blueprint Medicines Corporation | -486.27 Million USD | -16.5% |
| CalciMedica, Inc. | -21.87 Million USD | -2489.765% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -658.788% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -330.856% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -230.722% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -73.298% |
| Pulmatrix, Inc. | -14.74 Million USD | -3743.358% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -1484.868% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -537.489% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | -9.94% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -738.642% |
| Cytokinetics, Incorporated | -496.2 Million USD | -14.169% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -1545.925% |
| Nutriband Inc. | -4.87 Million USD | -11528.071% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -1198.95% |
| Vor Biopharma Inc. | -126.03 Million USD | -349.483% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 113.355% |
| Evogene Ltd. | -26.39 Million USD | -2046.607% |
| ProKidney Corp. | -151.52 Million USD | -273.88% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -777.835% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -7264.706% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 6.727% |
| CorMedix Inc. | -48.95 Million USD | -1057.142% |
| BioLineRx Ltd. | -49.69 Million USD | -1039.999% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -396.186% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -1387.999% |
| Atai Life Sciences N.V. | -125.47 Million USD | -351.508% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -593.92% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -595.883% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -127.525% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1742.912% |
| MediciNova, Inc. | -9.9 Million USD | -5622.18% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -348.285% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -7722.081% |
| GeoVax Labs, Inc. | -26.74 Million USD | -2018.357% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -144.37% |
| Biomea Fusion, Inc. | -126.13 Million USD | -349.131% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -62.137% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1893.634% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -196.464% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -146.358% |
| Absci Corporation | -115.51 Million USD | -390.422% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1953.543% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -401.928% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -133.939% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -2148.416% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -172.369% |
| Allakos Inc. | -196.05 Million USD | -188.954% |
| Imunon, Inc. | -21.03 Million USD | -2593.768% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -411.92% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 628.058% |
| BioAtla, Inc. | -129.68 Million USD | -336.829% |
| NLS Pharmaceutics AG | -11.8 Million USD | -4698.069% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -3475.781% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -72.855% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -1256.653% |
| XOMA Corporation | -41.84 Million USD | -1253.735% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -438.319% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -366.283% |
| aTyr Pharma, Inc. | -54.91 Million USD | -931.539% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -547.982% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -227.709% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -122.641% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -2539.108% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -6797.941% |
| Akari Therapeutics, Plc | -16.8 Million USD | -3270.885% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -6406199.651% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 267.818% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -8570.173% |
| UroGen Pharma Ltd. | -65.53 Million USD | -764.427% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -534.547% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -7699.946% |
| Orgenesis Inc. | -53.63 Million USD | -956.214% |
| Entera Bio Ltd. | -8.89 Million USD | -6271.735% |
| GH Research PLC | -41.22 Million USD | -1274.293% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -2103.637% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -582.108% |
| Xencor, Inc. | -138.63 Million USD | -308.623% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -10890.433% |
| Replimune Group, Inc. | -234.77 Million USD | -141.302% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -2536.024% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -3960.429% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -8570.173% |
| Portage Biotech Inc. | -18.25 Million USD | -3003.66% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -7722.081% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -439.735% |
| OncoCyte Corporation | -25.13 Million USD | -2153.783% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -4911.218% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -4844.645% |
| Purple Biotech Ltd. | 22.27 Million USD | 2643.716% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -7441.414% |
| scPharmaceuticals Inc. | -55.39 Million USD | -922.657% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -2897.779% |
| HilleVax, Inc. | -133.34 Million USD | -324.846% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -4601.726% |
| Tharimmune, Inc. | -9.45 Million USD | -5891.516% |
| Genprex, Inc. | -31.07 Million USD | -1723.011% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -201.025% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1705.498% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -73953.725% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -10300.577% |
| OKYO Pharma Limited | -15.74 Thousand USD | -3596856.9% |
| Savara Inc. | -60 Million USD | -844.075% |
| Curis, Inc. | -48.33 Million USD | -1072.124% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1736.943% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -10758.359% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -7684.953% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -1978.939% |
| BeiGene, Ltd. | -1.2 Billion USD | 53.093% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -2741.178% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | -16.283% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -504.911% |
| Erasca, Inc. | -141.52 Million USD | -300.29% |
| bluebird bio, Inc. | -244.26 Million USD | -131.928% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -12414.121% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 391.354% |
| DBV Technologies S.A. | -76.43 Million USD | -641.196% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -12414.121% |
| Moderna, Inc. | -4.23 Billion USD | 86.636% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1229.557% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -8807.406% |
| Molecular Templates, Inc. | -10.46 Million USD | -5312.87% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -742.558% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -50.37% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -295.302% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -989.591% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -266.574% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -172.191% |
| MacroGenics, Inc. | -168.24 Million USD | -236.72% |
| RenovoRx, Inc. | -11.39 Million USD | -4871.139% |
| Adicet Bio, Inc. | -152.03 Million USD | -272.611% |
| Prime Medicine, Inc. | -191.29 Million USD | -196.15% |
| Aditxt, Inc. | -26.06 Million USD | -2073.67% |
| Adagene Inc. | -23.71 Million USD | -2288.34% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7649.705% |
| Quantum-Si incorporated | -111.17 Million USD | -409.585% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1690.037% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3786.13% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 564.3% |
| SciSparc Ltd. | -5.77 Million USD | -9713.113% |
| Vericel Corporation | -6.46 Million USD | -8664.093% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -6444.218% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -2350.352% |
| Generation Bio Co. | -138.56 Million USD | -308.847% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -582.297% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -555.229% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -134.968% |
| Invivyd, Inc. | -207.78 Million USD | -172.646% |
| Relay Therapeutics, Inc. | -373 Million USD | -51.88% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -5940.526% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 2737.265% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -5407.057% |
| 2seventy bio, Inc. | -216.7 Million USD | -161.423% |
| ADMA Biologics, Inc. | 21.63 Million USD | 2718.856% |
| Clene Inc. | -40.54 Million USD | -1297.412% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -2252.83% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -933.855% |
| GeoVax Labs, Inc. | -26.74 Million USD | -2018.357% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -61.833% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -1442.281% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 3623.736% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -446.287% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -1566.111% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -232.698% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 17.214% |
| Evaxion Biotech A/S | -22.19 Million USD | -2452.196% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -587.664% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -153.9% |
| Trevena, Inc. | -35.28 Million USD | -1505.393% |
| Surrozen, Inc. | -45.78 Million USD | -1137.464% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -608.626% |
| Cingulate Inc. | -22.75 Million USD | -2389.153% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 7661.546% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -1168.299% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -6780.193% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -452.381% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -672.034% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -812.638% |
| Clearmind Medicine Inc. | -8.74 Million USD | -6380.818% |
| Kronos Bio, Inc. | -121.83 Million USD | -365.001% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -643.492% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -19215.169% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -461.864% |
| Statera Biopharma, Inc. | -98.34 Million USD | -476.052% |
| ImmunityBio, Inc. | -362.25 Million USD | -56.387% |
| Korro Bio, Inc. | -84.53 Million USD | -570.158% |
| Kineta, Inc. | -15.72 Million USD | -3503.072% |
| BioVie Inc. | -32.17 Million USD | -1660.467% |
| Codexis, Inc. | -68.06 Million USD | -732.26% |
| Celularity Inc. | -192.28 Million USD | -194.617% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -154.488% |
| Celcuity Inc. | -66.23 Million USD | -755.365% |
| Virax Biolabs Group Limited | -6.49 Million USD | -8620.286% |
| Cibus, Inc. | -318.88 Million USD | -77.655% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -1217.467% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -1573.889% |
| IN8bio, Inc. | -30.33 Million USD | -1767.393% |
| Kodiak Sciences Inc. | -277.32 Million USD | -104.28% |
| Annexon, Inc. | -143.72 Million USD | -294.169% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -357.635% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -776.328% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -2316.443% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -60.154% |
| Eyenovia, Inc. | -25.4 Million USD | -2129.792% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1835.634% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -10085.383% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -615.897% |
| Arcellx, Inc. | -89.88 Million USD | -530.297% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -1147.492% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -312.888% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1721.052% |
| Moolec Science SA | -6.65 Million USD | -8414.091% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -826.61% |
| Geron Corporation | -193.94 Million USD | -192.1% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -1209.761% |
| Royalty Pharma plc | 1.49 Billion USD | 137.966% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -245.093% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -5973.318% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -2487.439% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -231.376% |
| Humacyte, Inc. | -100.04 Million USD | -466.245% |
| Structure Therapeutics Inc. | -102.77 Million USD | -451.215% |
| 89bio, Inc. | -151.2 Million USD | -274.667% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -606.972% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -3796.224% |
| Genelux Corporation | -24.16 Million USD | -2244.345% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1569.991% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -229.846% |
| Notable Labs, Ltd. | -14.65 Million USD | -3765.122% |
| Liquidia Corporation | -73.38 Million USD | -671.982% |
| Mustang Bio, Inc. | -50.72 Million USD | -1016.806% |
| Immunovant, Inc. | -282.7 Million USD | -100.387% |
| Quantum-Si incorporated | -111.17 Million USD | -409.585% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -625.338% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -2563.803% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -455.338% |
| Acasti Pharma Inc. | -11.31 Million USD | -4908.053% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -2371.569% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -3445.267% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -164.658% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -15340.171% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -3466.102% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1842.967% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -1268.913% |
| PepGen Inc. | -84.76 Million USD | -568.323% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1811.886% |
| United Therapeutics Corporation | 1.18 Billion USD | 147.811% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2374.171% |
| Solid Biosciences Inc. | -104.31 Million USD | -443.077% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1626.74% |
| Immuneering Corporation | -58.41 Million USD | -869.839% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -11029.366% |
| Silo Pharma, Inc. | -3.85 Million USD | -14593.23% |
| Belite Bio, Inc | -31.66 Million USD | -1688.907% |
| XOMA Corporation | -41.84 Million USD | -1253.735% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -739.027% |
| Bionomics Limited | -17.89 Billion USD | 96.834% |
| Apogee Therapeutics, Inc. | -93 Million USD | -509.132% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1687.755% |
| uniQure N.V. | -282.87 Million USD | -100.272% |
| Cassava Sciences, Inc. | -105.95 Million USD | -434.661% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7649.705% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -337.447% |
| Forte Biosciences, Inc. | -32.48 Million USD | -1643.862% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -6718.242% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1827.236% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -10085.383% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3886.707% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -6273.169% |
| Altimmune, Inc. | -95.92 Million USD | -490.552% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -670.826% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1687.755% |
| Compugen Ltd. | -12.99 Million USD | -4260.46% |
| Peak Bio, Inc. | -1356.23 USD | -41770912.291% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -1042.067% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2418.946% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -133.803% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1804.495% |
| Zura Bio Limited | -62.63 Million USD | -804.421% |
| PolyPid Ltd. | -22.86 Million USD | -2377.417% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -3380.652% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1804.495% |
| Instil Bio, Inc. | -159.16 Million USD | -255.918% |
| argenx SE | -425.04 Million USD | -33.281% |
| Immunome, Inc. | -109.53 Million USD | -417.22% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -1024.856% |
| Verona Pharma plc | -67.83 Million USD | -735.181% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -2073.872% |
| Shattuck Labs, Inc. | -91.95 Million USD | -516.061% |
| CervoMed Inc. | -7.81 Million USD | -7150.974% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -674.875% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -4152.766% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -1075.968% |
| Moolec Science SA | -6.65 Million USD | -8414.091% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -3344.162% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -318.934% |
| AnaptysBio, Inc. | -164.41 Million USD | -244.57% |
| Design Therapeutics, Inc. | -78.19 Million USD | -624.531% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -550.855% |
| NeurAxis, Inc. | -6.66 Million USD | -8400.434% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -1298.827% |
| Lumos Pharma, Inc. | -36.61 Million USD | -1447.252% |
| Achilles Therapeutics plc | -75.25 Million USD | -652.789% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -2073.872% |
| 180 Life Sciences Corp. | -13.47 Million USD | -4103.383% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 11086.75% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -19215.169% |
| Nutriband Inc. | -4.87 Million USD | -11528.071% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -411.384% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -921.679% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -1014.389% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -757.064% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -946.708% |
| Palisade Bio, Inc. | -13.07 Million USD | -4234.438% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -1147.574% |
| Beam Therapeutics Inc. | -176.48 Million USD | -220.997% |
| Neurogene Inc. | -55.58 Million USD | -919.216% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -419.002% |
| AEON Biopharma, Inc. | -48.42 Million USD | -1069.776% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -485.783% |
| Sesen Bio, Inc. | -25.9 Million USD | -2086.541% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -578.221% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -4400.8% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | -23.005% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -682.052% |
| Athira Pharma, Inc. | -125.46 Million USD | -351.526% |
| Vaccinex, Inc. | -22.88 Million USD | -2375.469% |
| HCW Biologics Inc. | -25.71 Million USD | -2102.852% |
| XOMA Corporation | -41.84 Million USD | -1253.735% |
| Nektar Therapeutics | -137.42 Million USD | -312.233% |
| Arvinas, Inc. | -401.5 Million USD | -41.099% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -6406199.651% |
| Merus N.V. | -156.54 Million USD | -261.879% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -465.036% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -1536.369% |
| Rezolute, Inc. | -70.42 Million USD | -704.44% |
| Clene Inc. | -40.54 Million USD | -1297.412% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -3358.875% |
| BeyondSpring Inc. | -23.11 Million USD | -2350.943% |
| Synlogic, Inc. | -55.16 Million USD | -927.014% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -3059.747% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -5133.841% |
| Peak Bio, Inc. | -1356.23 USD | -41770912.291% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -1298.689% |
| Krystal Biotech, Inc. | -109.72 Million USD | -416.291% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -337.325% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -65.157% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -11836.717% |
| MannKind Corporation | 8.67 Million USD | 6628.129% |
| Ikena Oncology, Inc. | -75.41 Million USD | -651.171% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -5772.406% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -742.646% |
| Gossamer Bio, Inc. | -183.75 Million USD | -208.29% |
| CohBar, Inc. | -12.38 Million USD | -4472.953% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -1016.85% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1953.543% |
| Legend Biotech Corporation | -439.48 Million USD | -28.903% |
| Mural Oncology plc | -194.63 Million USD | -191.059% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -743.738% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -3408.836% |
| Disc Medicine, Inc. | -91.12 Million USD | -521.686% |
| Champions Oncology, Inc. | -7.35 Million USD | -7601.346% |
| REGENXBIO Inc. | -268.12 Million USD | -111.284% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -5185.511% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -916.054% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -1354.06% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -395.388% |
| Vaxart, Inc. | -83.34 Million USD | -579.702% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -6549.184% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -1223.807% |
| Cellectis S.A. | -106.62 Million USD | -431.307% |
| Longeveron Inc. | -21.02 Million USD | -2593.951% |
| Repare Therapeutics Inc. | -116.22 Million USD | -387.43% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -111.524% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -648.907% |
| Revolution Medicines, Inc. | -487.18 Million USD | -16.283% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -8416.401% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -1188.872% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -659.5% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -713.543% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -5044.955% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 113.152% |
| Denali Therapeutics Inc. | -196.69 Million USD | -188.009% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -6444.218% |
| Veru Inc. | -93.78 Million USD | -504.071% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -2328.355% |
| Cingulate Inc. | -22.75 Million USD | -2389.153% |
| Passage Bio, Inc. | -108.38 Million USD | -422.665% |
| Context Therapeutics Inc. | -25.07 Million USD | -2159.481% |
| Exicure, Inc. | -14.99 Million USD | -3677.747% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -174.92% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -1295.416% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -5730.14% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -207.29% |
| Nuvalent, Inc. | -149.49 Million USD | -278.957% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -6794.79% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -538.459% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -2627.019% |
| OmniAb, Inc. | -69.41 Million USD | -716.075% |
| Anew Medical, Inc. | -1.3 Million USD | -43449.629% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -4335.917% |
| Lipocine Inc. | -17.93 Million USD | -3059.402% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -726.866% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -643.921% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1387.869% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -1333.225% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -2430.875% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 2.3% |
| Ocugen, Inc. | -65.53 Million USD | -764.493% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -503.532% |
| Q32 Bio Inc. | -92.1 Million USD | -515.091% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -2542.432% |
| Alumis Inc. Common Stock | -158.17 Million USD | -258.157% |
| Equillium, Inc. | -14.52 Million USD | -3801.054% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -807.783% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -7067.987% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2902.957% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -1106.6% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -422.294% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -4632.751% |
| Dominari Holdings Inc. | -21.79 Million USD | -2499.151% |
| Edesa Biotech, Inc. | -9.22 Million USD | -6042.534% |
| vTv Therapeutics Inc. | -25.5 Million USD | -2121.438% |
| Bio-Techne Corporation | 206.68 Million USD | 374.093% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -44.707% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 395.012% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -328.276% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -1375.635% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -274.922% |
| Nkarta, Inc. | -131.65 Million USD | -330.316% |
| BioCardia, Inc. | -11.64 Million USD | -4765.261% |
| Iterum Therapeutics plc | -47.46 Million USD | -1093.459% |